Literature DB >> 34851691

Repeated Plasmodium falciparum infection in humans drives the clonal expansion of an adaptive γδ T cell repertoire.

Anouk von Borstel1, Priyanka Chevour1, Daniel Arsovski1, Jelte M M Krol2,3, Lauren J Howson1, Andrea A Berry4, Cheryl L Day5, Paul Ogongo6,7, Joel D Ernst6, Effie Y H Nomicos8, Justin A Boddey2,3, Edward M Giles9, Jamie Rossjohn1,10,11, Boubacar Traore12, Kirsten E Lyke4, Kim C Williamson13, Peter D Crompton14, Martin S Davey1.   

Abstract

Repeated Plasmodium falciparum infections drive the development of clinical immunity to malaria in humans; however, the immunological mechanisms that underpin this response are only partially understood. We investigated the impact of repeated P. falciparum infections on human γδ T cells in the context of natural infection in Malian children and adults, as well as serial controlled human malaria infection (CHMI) of U.S. adults, some of whom became clinically immune to malaria. In contrast to the predominant Vδ2+ T cell population in malaria-naïve Australian individuals, clonally expanded cytotoxic Vδ1effector T cells were enriched in the γδ T cell compartment of Malian subjects. Malaria-naïve U.S. adults exposed to four sequential CHMIs defined the precise impact of P. falciparum on the γδ T cell repertoire. Specifically, innate-like Vδ2+ T cells exhibited an initial robust polyclonal response to P. falciparum infection that was not sustained with repeated infections, whereas Vδ1+ T cells increased in frequency with repeated infections. Moreover, repeated P. falciparum infection drove waves of clonal selection in the Vδ1+ T cell receptor repertoire that coincided with the differentiation of Vδ1naïve T cells into cytotoxic Vδ1effector T cells. Vδ1+ T cells of malaria-exposed Malian and U.S. individuals were licensed for reactivity to P. falciparum parasites in vitro. Together, our study indicates that repeated P. falciparum infection drives the clonal expansion of an adaptive γδ T cell repertoire and establishes a role for Vδ1+ T cells in the human immune response to malaria.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34851691      PMCID: PMC9291638          DOI: 10.1126/scitranslmed.abe7430

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   19.319


  64 in total

1.  High frequency of circulating gamma delta T cells with dominance of the v(delta)1 subset in a healthy population.

Authors:  L Hviid; B D Akanmori; S Loizon; J A Kurtzhals; C H Ricke; A Lim; K A Koram; F K Nkrumah; O Mercereau-Puijalon; C Behr
Journal:  Int Immunol       Date:  2000-06       Impact factor: 4.823

Review 2.  Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity.

Authors:  Marc Bonneville; Rebecca L O'Brien; Willi K Born
Journal:  Nat Rev Immunol       Date:  2010-06-11       Impact factor: 53.106

Review 3.  Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators?

Authors:  Chiara Riganti; Massimo Massaia; Martin S Davey; Matthias Eberl
Journal:  Eur J Immunol       Date:  2012-07       Impact factor: 5.532

4.  Treatment of Chronic Asymptomatic Plasmodium falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection.

Authors:  Silvia Portugal; Tuan M Tran; Aissata Ongoiba; Aboudramane Bathily; Shanping Li; Safiatou Doumbo; Jeff Skinner; Didier Doumtabe; Younoussou Kone; Jules Sangala; Aarti Jain; D Huw Davies; Christopher Hung; Li Liang; Stacy Ricklefs; Manijeh Vafa Homann; Philip L Felgner; Stephen F Porcella; Anna Färnert; Ogobara K Doumbo; Kassoum Kayentao; Brian M Greenwood; Boubacar Traore; Peter D Crompton
Journal:  Clin Infect Dis       Date:  2017-03-01       Impact factor: 9.079

5.  Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria.

Authors:  L Hviid; J A Kurtzhals; V Adabayeri; S Loizon; K Kemp; B Q Goka; A Lim; O Mercereau-Puijalon; B D Akanmori; C Behr
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues.

Authors:  B Falini; L Flenghi; S Pileri; P Pelicci; M Fagioli; M F Martelli; L Moretta; E Ciccone
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

Review 7.  Human unconventional T cells in Plasmodium falciparum infection.

Authors:  Mathias Schmaler; Nina Orlova-Fink; Tobias Rutishauser; Salim Abdulla; Claudia Daubenberger
Journal:  Semin Immunopathol       Date:  2020-02-19       Impact factor: 9.623

8.  Loss and dysfunction of Vδ2⁺ γδ T cells are associated with clinical tolerance to malaria.

Authors:  Prasanna Jagannathan; Charlie C Kim; Bryan Greenhouse; Felistas Nankya; Katherine Bowen; Ijeoma Eccles-James; Mary K Muhindo; Emmanuel Arinaitwe; Jordan W Tappero; Moses R Kamya; Grant Dorsey; Margaret E Feeney
Journal:  Sci Transl Med       Date:  2014-08-27       Impact factor: 17.956

9.  Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.

Authors:  Guangyong Peng; Helen Y Wang; Weiyi Peng; Yukiko Kiniwa; Kook Heon Seo; Rong-Fu Wang
Journal:  Immunity       Date:  2007-07-26       Impact factor: 31.745

Review 10.  Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?

Authors:  Gabrielle M Siegers; Lawrence S Lamb
Journal:  Mol Ther       Date:  2014-06-04       Impact factor: 11.454

View more
  2 in total

1.  Evidence for an Adult-Like Type 1-Immunity Phenotype of Vδ1, Vδ2 and Vδ3 T Cells in Ghanaian Children With Repeated Exposure to Malaria.

Authors:  Ximena León-Lara; Tao Yang; Alina Suzann Fichtner; Elena Bruni; Constantin von Kaisenberg; Britta Eiz-Vesper; Daniel Dodoo; Bright Adu; Sarina Ravens
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

2.  Transcriptional profiling of human Vδ1 T cells reveals a pathogen-driven adaptive differentiation program.

Authors:  Jack L McMurray; Anouk von Borstel; Taher E Taher; Eleni Syrimi; Graham S Taylor; Maria Sharif; Jamie Rossjohn; Ester B M Remmerswaal; Frederike J Bemelman; Felipe A Vieira Braga; Xi Chen; Sarah A Teichmann; Fiyaz Mohammed; Andrea A Berry; Kirsten E Lyke; Kim C Williamson; Michael J T Stubbington; Martin S Davey; Carrie R Willcox; Benjamin E Willcox
Journal:  Cell Rep       Date:  2022-05-24       Impact factor: 9.995

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.